Novo Holdings A/S’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.1M | Hold |
5,350,000
| – | – | 4.95% | 6 |
|
|
2025
Q1 | $118M | Buy |
5,350,000
+350,000
| +7% | +$7.7M | 8.95% | 3 |
|
|
2024
Q4 | $134M | Sell |
5,000,000
-549,900
| -10% | -$14.7M | 8.08% | 4 |
|
|
2024
Q3 | $148M | Sell |
5,549,900
-794,530
| -13% | -$21.2M | 7.36% | 4 |
|
|
2024
Q2 | $114M | Buy |
+6,344,430
| New | +$114M | 6.16% | 6 |
|
|
2024
Q1 | – | Sell |
-6,071,703
| Closed | -$66.4M | – | 36 |
|
|
2023
Q4 | $66.4M | Hold |
6,071,703
| – | – | 4.1% | 8 |
|
|
2023
Q3 | $34.8M | Hold |
6,071,703
| – | – | 2.57% | 15 |
|
|
2023
Q2 | $47.1M | Hold |
6,071,703
| – | – | 3.64% | 8 |
|
|
2023
Q1 | $40.5M | Hold |
6,071,703
| – | – | 2.67% | 13 |
|
|
2022
Q4 | $54.3M | Hold |
6,071,703
| – | – | 3.39% | 10 |
|
|
2022
Q3 | $59.7M | Buy |
6,071,703
+484,496
| +9% | +$4.77M | 2.85% | 13 |
|
|
2022
Q2 | $44.5M | Hold |
5,587,207
| – | – | 2.19% | 15 |
|
|
2022
Q1 | $54.2M | Hold |
5,587,207
| – | – | 2.86% | 11 |
|
|
2021
Q4 | $85.4M | Hold |
5,587,207
| – | – | 4.04% | 7 |
|
|
2021
Q3 | $92.7M | Hold |
5,587,207
| – | – | 4.8% | 6 |
|
|
2021
Q2 | $119M | Hold |
5,587,207
| – | – | 5.29% | 6 |
|
|
2021
Q1 | $182M | Buy |
+5,587,207
| New | +$182M | 7.5% | 2 |
|